Published on 11/16/2006 in the Prospect News Biotech Daily.
New Issue: Hansen raises $75 million in IPO of 6.25 million shares at $12 each - middle of talk at $11-$13
By Ronda Fears
Memphis, Nov. 16 - Hansen Medical, Inc. raised $75 million from its initial public offering of 6.25 million shares at $12 each, the middle of guidance of $11 to $13 per share, via joint bookrunners Morgan Stanley & Co. and J.P. Morgan Securities Inc.
The Mountain View, Calif.-based company, which develops and manufactures robotics designed to position, manipulate and control catheter technologies, plans to use proceeds for sales, marketing and general corporate purposes.
Issuer: | Hansen Medical, Inc.
|
Issue: | Initial public offering
|
Gross proceeds: | $75 million
|
Net proceeds: | $69.75 million
|
Shares: | 6.25 million
|
Greenshoe: | 937,500 shares
|
Price: | $12 per share
|
Price talk: | $11 to $13 per share
|
Joint bookrunners: | Morgan Stanley & Co. and J.P. Morgan Securities Inc.
|
Co-managers: | Thomas Weisel Partners LLC and Leerink Swann & Co.
|
Pricing date: | Nov. 15
|
Settlement date: | Nov. 21
|
Stock symbol: | Nasdaq: HNSN
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.